SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-099484
Filing Date
2018-03-28
Accepted
2018-03-28 16:07:04
Documents
3
Period of Report
2018-03-28

Document Format Files

Seq Description Document Type Size
1 6-K d524311d6k.htm 6-K 9433
2 EX-99.1 d524311dex991.htm EX-99.1 65977
3 GRAPHIC g524311img1.jpg GRAPHIC 12232
  Complete submission text file 0001193125-18-099484.txt   93358
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 18718825
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1